Trial intelligence / Profile preview

Intravenous pantomicina (erythromycin lactobionate) infusion prior to gastroscopy in upper gastrointestinal bleeding

2010-024639-18Phase 4Active

Sponsor
Servicio Digestivo
Start
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of erythromycin in upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by Servicio Digestivo. Primary endpoint: Identification of bleeding point. Started Nov 2011; status: active.

02

Drugs

erythromycin
03

Conditions

upper gastrointestinal bleeding (UGIB)

Beyond the preview

Go deeper on 2010-024639-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-024639-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call